Prader-Willi syndrome-Clinical Trial Insight

Prader-Willi syndrome-Clinical Trial Insight

  • DelveInsight
  • September 2020
  • Diseases & Conditions
  • 90 pages
Introduction
Executive Summary
Prader-Willi syndrome: Overview
Causes
Mechanism of Action
Signs and Symptoms
Diagnosis
Disease Management
Pipeline Therapeutics
Comparative Analysis
Therapeutic Assessment
Assessment by Product Type
Assessment by Stage and Product Type
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type
Prader-Willi syndrome DelveInsights Analytical Perspective
In-depth Commercial Assessment
Prader-Willi syndrome companies collaborations, Licensing, Acquisition -Deal Value Trends
Prader-Willi syndrome Collaboration Deals
Company-Company Collaborations (Licensing / Partnering) Analysis
Company-University Collaborations (Licensing / Partnering) Analysis
Late Stage Products (Phase III)
Comparative Analysis
BSN175: Biospherics.net
Product Description
Research and Development
Product Development Activities
Mid Stage Products (Phase II)
Comparative Analysis
Pitolisant: Harmony Biosciences
Product Description
Research and Development
Product Development Activities
Drug profiles in the detailed report..
Early Stage Products (Phase I)
Comparative Analysis
OPN-300: OptiNose
Product Description
Research and Development
Product Development Activities
Drug profiles in the detailed report..
Pre-clinical and Discovery Stage Products
Comparative Analysis
INV-101: Inversago Pharma
Product Description
Research and Development
Product Development Activities
Inactive Products
Comparative Analysis
Prader-Willi syndrome Key Companies
Prader-Willi syndrome Key Products
Prader-Willi syndrome- Unmet Needs
Prader-Willi syndrome- Market Drivers and Barriers
Prader-Willi syndrome- Future Perspectives and Conclusion
Prader-Willi syndrome Analyst Views
Prader-Willi syndrome Key Companies
Appendix
Table 1 Total Products for Prader-Willi syndrome
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products
Figure 1 Total Products for Prader-Willi syndrome
Figure 2 Late Stage Products
Figure 3 Mid Stage Products
Figure 4 Early Stage Products
Figure 5 Preclinical and Discovery Stage Products
Figure 6 Assessment by Product Type
Figure 7 Assessment by Stage and Product Type
Figure 8 Assessment by Route of Administration
Figure 9 Assessment by Stage and Route of Administration
Figure 10 Assessment by Molecule Type
Figure 11 Assessment by Stage and Molecule Type
Figure 12 Inactive Products

Have query on this report?

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074